|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ganly I, Patel S and Shah J: Early stage
squamous cell cancer of the oral tongue - clinicopathologic
features affecting outcome. Cancer. 118:101–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Süslü N, Hoşal AS, Aslan T, Sözeri B and
Dougun A: Carcinoma of the oral tongue: A case series analysis of
prognostic factors and surgical outcomes. J Oral Maxillofac Surg.
71:1283–1290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling W, Mijiti A and Moming A: Survival
pattern and prognostic factors of patients with squamous cell
carcinoma of the tongue: A retrospective analysis of 210 cases. J
Oral Maxillofac Surg. 71:775–785. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shah JP and Gil Z: Current concepts in
management of oral cancer - surgery. Oral Oncol. 45:394–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanamoto S, Yamada S, Takahashi H,
Kawasaki G, Ikeda H, Shiraishi T, Fujita S, Ikeda T, Asahina I and
Umeda M: Predictors of locoregional recurrence in T1-2N0 tongue
cancer patients. Pathol Oncol Res. 19:795–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Rajhi N, Khafaga Y, EIHusseiny J,
Saleem M, Mourad W, Al-Otieschan A and Al-Amro A: Early stage
carcinoma of oral tongue: prognostic factors for local control and
survival. Oral Oncol. 36:508–514. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsumoto K, Sasaki T, Shioyama Y, et al:
Treatment outcome of high-dose-rate interstitial radiation therapy
for patients with stage I and II mobile tongue cancer. Jpn J Clin
Oncol. 43:1012–1017. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirota K, Wakisaka N, SawadaKitamura S,
Kondo S, Endo K, Tsuji A, Murono S and Yoshizaki T:
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence
in pathological NO squamous cell carcinoma of the tongue.
Histopathology. 61:1065–1071. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
D'Cruz AK, Siddachari RC, Walvekar RR,
Pantvaidya GH, Chaukar DA, Deshpande MS, Pai PS and Chaturvedi P:
Elective neck dissection for the management of the NO neck in early
cancer of the oral tongue: Need for a randomized controlled trial.
Head Neck. 31:618–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tammela T and Alitalo K:
Lymphangiogenesis: Molecular mechanisms and future promise. Cell.
140:460–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Achen MG, McColl BK and Stacker SA: Focus
on lymphangiogenesis in tumor metastasis. Cancer Cell. 7:121–127.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karpanen T and Alitalo K: Molecular
biology and pathology of lymphangiogenesis. Annu Rev Pathol.
3:367–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tobler NE and Detmar M: Tumor and lymph
node lymphangiogenesis - impact on cancer metastasis. J Leukoc
Biol. 80:691–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Otrock ZK, Makarem JA and Shamseddine AI:
Vascular endothelial growth factor family of ligands and receptors:
Review. Blood Cells Mol Dis. 38:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kitadai Y, Amioka T, Haruma K, Tanaka S,
Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K:
Clinicopathological significance of vascular endothelial growth
factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J
Cancer. 93:662–666. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Omoto I, Matsumoto M, Okumura H, et al:
Expression of vascular endothelial growth factor-C and vascular
endothelial growth factor receptor-3 in esophageal squamous cell
carcinoma. Oncol Lett. 7:1027–1032. 2014.PubMed/NCBI
|
|
19
|
Han FH, Li HM, Zheng DH, He YL and Zhan
WH: The effect of the expression of vascular endothelial growth
factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in
patients with gastric carcinoma. Eur J Surg Oncol. 36:1172–1179.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Witte D, Thomas A, Ali N, Carlson N and
Younes M: Expression of the vascular endothelial growth factor
receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal
adenocarcinoma. Anticancer Res. 22:1463–1466. 2002.PubMed/NCBI
|
|
21
|
Arinaga M, Noguchi T, Takeno S, Chujo M,
Miura T and Uchida Y: Clinical significance of vascular endothelial
growth factor C and vascular endothelial growth factor receptor 3
in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Botting SK, Fouad H, Elwell K, Rampy BA,
Salama SA, Freeman DH and Diaz-Arrastia CR: Prognostic significance
of peritumoral lymphatic vessel density and vascular endothelial
growth factor receptor 3 in invasive squamous cell cervical cancer.
Transl Oncol. 3:170–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
VanTrappen PO, Steele D, Lowe DG, et al:
Expression of vascular endothelial growth factor (VEGF)-C and
VEGF-D and their receptor VEGFR-3, during different stages of
cervical carcinogenesis. J Pathol. 201:544–554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jennbacken K, Vallbo C, Wang W and Damber
JE: Expression of vascular endothelial growth factor C (VEGF-C) and
VEGF receptor-3 in human prostate cancer is associated with
regional lymph node metastasis. Prostate. 65:110–116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wakisaka N, Hirota K, Kondo S,
SawadaKitamura S, Endo K, Murono S and Yoshizaki T: Induction of
lymphangiogenesis through vascular endothelial growth
factor-C/vascular endothelial growth factor receptor 3 axis and its
correlation with lymph node metastasis in nasopharyngeal carcinoma.
Oral Oncol. 48:703–708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yanamoto S, Yamada S, Takahashi H, et al:
Expression of the cancer stem cell markers CD44v6 and ABCG2 in
tongue cancer: Effect of neoadjuvant chemotherapy on local
recurrence. Int J Oncol. 44:1153–1162. 2014.PubMed/NCBI
|
|
27
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: World Health Organization International Histological
Classification of TumoursHistological Typing of Cancer and
Precancer of the Oral Mucosa. 2nd. Springer; Berlin: pp. 33–40.
1997, View Article : Google Scholar
|
|
28
|
Bryne M, Boysen M, Alfsen CG, Abeler VM,
Sudbø J, Nesland JM, Kristensen GB, Piffko J and Bankfalvi A: The
invasive front of carcinomas. The most important area for tumour
prognosis? Anticancer Res. 18:4757–4764. 1998.PubMed/NCBI
|
|
29
|
Asakage T, Yokose T, Mukai K, Tsugane S,
Tsubono Y, Asai M and Ebihara S: Tumor thickness predicts cervical
metastasis in patients with stage I/II carcinoma of the tongue.
Cancer. 82:1443–1448. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurokawa H, Yamashita Y, Takeda S, Zhang
M, Fukuyama H and Takahashi T: Risk factors for late cervical lymph
node metastases in patients with stage I or II carcinoma of the
tongue. Head Neck. 24:731–736. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lim SC, Zhang S, Ishli G, Endoh Y, Kodama
K, Miyamoto S, Hayashi R, Ebihara S, Cho JS and Ochiai A:
Predictive markers for late cervical metastasis in stage I and II
invasive squamous cell carcinoma of the oral tongue. Clin Cancer
Res. 10:166–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sparano A, Weinstein G, Chalian A, Yodul M
and Weber R: Multivariate predictors of occult neck metastasis in
early oral tongue cancer. Otolaryngol Head Neck Surg. 131:472–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang SH, Hwang D, Lockwood G, Goldstein
DP and O'Sullivan B: Predictive value of tumor thickness for
cervical lymph-node involvement in squamous cell carcinoma of the
oral cavity: A meta-analysis of reported studies. Cancer.
115:1489–1497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Naruse T, Kawasaki G, Yanamoto S, Mizuno A
and Umeda M: Immunohistochemical study of VEGF expression in oral
squamous cell carcinomas: Correlation with the mTOR-HIF-1α pathway.
Anticancer Res. 31:4429–4437. 2011.PubMed/NCBI
|
|
35
|
Watanabe S, Kato M, Kotani I, Ryoke K and
Hayashi K: Lymphatic vessel density and vascular endothelial growth
factor expression in squamous cell carcinomas of lip and oral
cavity: A clinicopathological analysis with immunohistochemistry
using antibodies to D2-40, VEGF-C and VEGF-D. Yonago Acta Med.
56:29–37. 2013.PubMed/NCBI
|
|
36
|
de Vicente JC, Rodrigo JP,
RodriguezSantamarta T, Lequerica-Fernández P, Allonca E and
García-Pedrero JM: Podoplanin expression in oral leukoplakia:
tumorigenic role. Oral Oncol. 49:598–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Okada Y: Relationships of cervical lymph
node metastasis to histopathological malignancy grade, tumor
angiogenesis and lymphatic invasion in tongue cancer. Odontology.
98:153–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan P, Temam S, EINaggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
